BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11363073)

  • 1. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saquinavir gets accelerated approval.
    McGuire S
    Posit Aware; 1996; 7(1):8. PubMed ID: 11363135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lottery opens 2,000 slots for protease trial.
    AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitor: Roche lottery deadline July 21.
    AIDS Treat News; 1995 Jul; (no 226):4-5. PubMed ID: 11362614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saquinavir (Invirase).
    Treat Rev; 1996 Apr; (no 21):5. PubMed ID: 11363396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roche submits NDA for Invirase.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European hurdles for saquinavir.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No tease this time--pros and cons of a long-awaited anti-HIV drug.
    Chang HE
    Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA approves 3TC and saquinavir. Food and Drug Administration.
    Baker R
    BETA; 1995 Dec; ():5, 9. PubMed ID: 11363011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinder, gentler ddC... for $7,200 a year.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saquinavir: newest weapon in the antiviral arsenal.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):25-31. PubMed ID: 11363336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New formulation of saquinavir (Fortovase) is more effective.
    Tam CW
    Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saquinavir: combination shows survival benefit; new formulation trial recruiting.
    AIDS Treat News; 1996 May; (no 246):1-2. PubMed ID: 11363484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor trials moving to next phase.
    AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New protease inhibitor studies.
    Treat Rev; 1995 Nov; (no 20):3. PubMed ID: 11363020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saquinavir (Roche protease inhibitor) at higher doses.
    AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saquinavir with grapefruit juice.
    Posit Aware; 1996; 7(1):5. PubMed ID: 11363122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invirase compassionate use program.
    AIDS Patient Care; 1995 Oct; 9(5):256. PubMed ID: 11361410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.